Home/Filings/4/0001179110-12-013784
4//SEC Filing

Nelson Arlin D 4

Accession 0001179110-12-013784

CIK 0000856982other

Filed

Sep 6, 8:00 PM ET

Accepted

Sep 7, 4:30 PM ET

Size

18.2 KB

Accession

0001179110-12-013784

Insider Transaction Report

Form 4
Period: 2012-09-06
Nelson Arlin D
Chief Operating Officer
Transactions
  • Exercise/Conversion

    Common Stock, No Par Value

    2012-09-06$7.79/sh+11,111$86,55511,411 total
  • Sale

    Common Stock, No Par Value

    2012-09-06$14.61/sh11,111$162,332300 total
  • Exercise/Conversion

    Non-qualified Stock Options (right to buy)

    2012-09-0611,1110 total
    Exercise: $7.79From: 2003-02-06Exp: 2013-02-06Common Stock (11,111 underlying)
Holdings
  • Common Stock, No Par Value

    (indirect: By 401(k))
    928
  • Non-qualified Stock Options (right to buy)

    Exercise: $17.34From: 2003-12-13Exp: 2013-12-13Common Stock (4,375 underlying)
    4,375
  • Non-qualified Stock Options (right to buy)

    Exercise: $9.71From: 2005-12-28Exp: 2015-12-28Common Stock (12,500 underlying)
    12,500
  • Non-qualified Stock Options (right to buy)

    Exercise: $12.02From: 2004-12-18Exp: 2014-12-18Common Stock (12,500 underlying)
    12,500
  • Non-qualified stock options (right to buy)

    Exercise: $11.53From: 2009-05-21Exp: 2015-05-21Common Stock (31,250 underlying)
    31,250
  • Non-qualified stock options (right to buy)

    Exercise: $13.75From: 2012-08-11Exp: 2018-08-11Common Stock (25,000 underlying)
    25,000
  • Non-qualified Stock Options (right to buy)

    Exercise: $11.05From: 2004-06-10Exp: 2014-06-10Common Stock (1,875 underlying)
    1,875
  • Non-qualified Stock Options (right to buy)

    Exercise: $9.70From: 2008-06-27Exp: 2014-06-27Common Stock (25,000 underlying)
    25,000
Footnotes (5)
  • [F1]Represents plan holdings as of 09/06/12.
  • [F2]Becomes exercisable in equal annual installments of 20% commencing 06/27/08.
  • [F3]Becomes exercisable in equal annual installments of 20% commencing 05/21/09.
  • [F4]Becomes exercisable in equal annual installments of 20% commencing 08/11/12.
  • [F5]The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $14.54 to $14.67, inclusive. The reporting person undertakes to provide to Merit Medical Systems, Inc., any security holder of Merit Medical Systems, Inc., or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this Form 4.

Issuer

MERIT MEDICAL SYSTEMS INC

CIK 0000856982

Entity typeother

Related Parties

1
  • filerCIK 0001382939

Filing Metadata

Form type
4
Filed
Sep 6, 8:00 PM ET
Accepted
Sep 7, 4:30 PM ET
Size
18.2 KB